Business Context and Reporting Period
Company: Byrna Technologies Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 10, 2026
Event Date: August 6, 2026 (Closing Date)
Principal Activity: Completion of the acquisition of substantially all assets of Hero Defense Systems, LLC ("Hero"), a developer and manufacturer of less-lethal defense products.
Key Financial Metrics and Transaction Details
This filing details a specific asset acquisition rather than periodic financial performance. Key transaction metrics include:
- Total Consideration Structure:
- Cash: $625,000 total ($500,000 immediate; $125,000 held in escrow for 18 months).
- Equity: 104,000 shares of Common Stock issued to Hero's two members.
- Liabilities: Assumption of certain specified liabilities of Hero.
- Royalty Obligation: 3.5% of net sales of Hero products and derivatives.
- Royalty Guarantees:
- Guaranteed minimum aggregate royalty: $250,000 (payable in five annual installments of $50,000).
- Termination cap: Payments cease upon reaching $5,000,000 aggregate or the fifth anniversary of the Closing Date, whichever is earlier.
Liquidity and Debt: The filing does not provide updated consolidated balance sheet data, cash flow statements, or total debt levels for Byrna Technologies Inc. post-acquisition.
Material Changes Versus Prior Period
The primary material change is the expansion of Byrna's product portfolio and intellectual property through the acquisition of Hero Defense Systems. The company has incurred immediate cash outflows and equity dilution (104,000 shares) and established a long-term contingent liability via the royalty agreement. No pro forma financial information was provided in this filing to quantify the impact on historical financial metrics.
Guidance, Outlook, and Risks
- Management Commentary: The filing confirms the strategic intent to integrate Hero's less-lethal defense products and accessories into Byrna's existing business.
- Restrictions: The 104,000 shares issued are restricted securities subject to a six-month lock-up period and other transfer restrictions.
- Risks and Contingencies:
- Indemnification: $125,000 of the cash consideration is held in escrow to secure Hero's indemnification obligations.
- Future Cash Outflows: The company is committed to minimum royalty payments totaling $250,000 over five years, regardless of sales performance.
- Unusual Items: The transaction included consulting arrangements with Hero's two principals and restrictive covenant agreements.
Investor Verification Checklist
- Verify the market value of the 104,000 shares issued at the time of closing to assess total deal value.
- Review the full Asset Purchase Agreement (Exhibit 2.1) for details on the "specified liabilities" assumed.
- Monitor future 10-Q/10-K filings for the impact of the 3.5% royalty on gross margins and operating expenses.
- Confirm the integration timeline and any synergies realized from the Hero product line in subsequent earnings releases.
- Check for any material changes to the $125,000 escrow balance during the 18-month security period.